OverviewSuggest Edit

Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins. The Company has developed a high-quality protein production and bioanalytic technology platform approach that allows them to create biosimilars in a highly efficient manner.

Pfenex's patented protein production platform, Pfenex Expression Technology, enables its ability to produce complex proteins relative to other systems. With advantages including quality, stability, solubility, and purity, Pfenex reduces production and development costs that enable the rapid delivery of protein products into clinical development and commercialization.

TypePublic
Founded2009
HQSan Diego, US
Websitepfenex.com
Employee Ratings3

Latest Updates

Employees (est.) (Dec 2018)71(+6%)
Job Openings1
Revenue (FY, 2018)$14.9 M(-48%)
Share Price (Oct 2019)$8.9 (+4%)

Key People/Management at Pfenex

Patrick Lucy

Patrick Lucy

VP Business Development
Albert Hansen

Albert Hansen

Director
James C. Gale

James C. Gale

Director
Eef Schimmelpennink

Eef Schimmelpennink

CEO, President and Secretary
Show more

Pfenex Office Locations

Pfenex has an office in San Diego
San Diego, US (HQ)
10790 Roselle St
Show all (1)

Pfenex Financials and Metrics

Pfenex Revenue

Embed Graph
View revenue for all periods
Pfenex's revenue was reported to be $14.86 m in FY, 2018
USD

Revenue (Q2, 2019)

2.8m

Gross profit (Q2, 2019)

1.7m

Gross profit margin (Q2, 2019), %

60.1%

Net income (Q2, 2019)

(7.6m)

EBIT (Q2, 2019)

(7.7m)

Market capitalization (11-Oct-2019)

280.6m

Closing stock price (11-Oct-2019)

8.9

Cash (30-Jun-2019)

41.6m

EV

239.3m
Pfenex's current market capitalization is $280.6 m.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

9.6m60.2m28.8m14.9m

Cost of goods sold

4.6m5.3m5.2m5.0m

Gross profit

4.9m54.9m23.6m9.8m

Gross profit Margin, %

52%91%82%66%
Quarterly
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

3.3m2.8m2.3m2.1m2.8m3.1m48.8m2.8m3.0m5.0m3.7m4.2m3.6m10.4m2.8m

Cost of goods sold

2.5m1.6m921.0k682.0k1.3m1.4m1.3m810.0k905.0k1.8m1.5m924.0k1.5m1.6m1.1m

Gross profit

722.0k1.2m1.4m1.4m1.5m1.7m47.5m2.0m2.1m3.3m2.2m3.3m2.1m8.8m1.7m

Gross profit Margin, %

22%44%60%67%54%54%97%71%70%65%59%78%59%85%60%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

106.2m81.5m57.7m56.2m

Inventories

24.0k

Current Assets

115.0m86.9m61.5m63.6m

PP&E

3.2m5.2m7.4m7.7m
Quarterly
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

3.9m51.5m123.0m115.9m96.5m89.6m93.6m70.2m59.9m48.4m47.1m80.2m67.8m45.8m41.6m

Inventories

31.0k25.0k

Current Assets

10.7m57.6m130.5m122.6m102.1m94.2m97.4m74.2m63.6m54.3m50.3m83.7m71.9m54.7m46.9m

PP&E

2.1m2.0m2.7m3.1m4.1m4.4m5.1m5.5m6.3m7.3m7.4m7.4m7.5m7.6m7.5m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(28.2m)5.5m(25.7m)(39.6m)

Depreciation and Amortization

541.0k670.0k876.0k1.1m

Inventories

(1.0k)

Accounts Payable

(243.0k)431.0k628.0k68.0k
USDY, 2019

EV/EBIT

-31.1 x

EV/CFO

-16.8 x

Financial Leverage

1.2 x
Show all financial metrics

Pfenex Online and Social Media Presence

Embed Graph

Pfenex News and Updates

Thinking about buying stock in Aurora Cannabis, Coca-Cola, Match Group, Pfenex, or RingCentral?

NEW YORK, Oct. 7, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, KO, MTCH, PFNX, and RNG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis

Pfenex earns a $2.5M milestone payment from Alvogen for U.S. approval

Pfenex to Participate at the William Blair Late-Stage Therapeutics Conference

SAN DIEGO, March 27, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet patient needs, announced today that Eef Schimmelpennink, …

Pfenex Reports Fourth Quarter and Full Year 2018 Results and Provides Business Update

We believe PF708 is on track to enter the U.S. market as early as Q4 2019, subject to FDA approval and other factors

Pfenex Reports New Employment Inducement Award Under NYSE American Listing Rules

SAN DIEGO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) (“Pfenex” or the “Company”), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve protein therapies for unmet patient needs, today reported,…

Pfenex to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference

SAN DIEGO, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today that it will be presenting at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York.
Show more

Pfenex Blogs

Pfenex Provides Update for PF708 Outside the United States

New Exclusive Commercialization Agreements in South Korea, Canada, and Israel | Submission of Marketing Authorization Application for PF708 in Saudi Arabia | Potential approval of PF708 in the EU as early as the second half of 2020
Show more

Pfenex Frequently Asked Questions

  • When was Pfenex founded?

    Pfenex was founded in 2009.

  • Who are Pfenex key executives?

    Pfenex's key executives are Patrick Lucy, Albert Hansen and James C. Gale.

  • How many employees does Pfenex have?

    Pfenex has 71 employees.

  • What is Pfenex revenue?

    Latest Pfenex annual revenue is $14.9 m.

  • What is Pfenex revenue per employee?

    Latest Pfenex revenue per employee is $209.3 k.

  • Who are Pfenex competitors?

    Competitors of Pfenex include U.S. Stem Cell, Enanta Pharmaceuticals and Endologix.

  • Where is Pfenex headquarters?

    Pfenex headquarters is located at 10790 Roselle St, San Diego.

  • Where are Pfenex offices?

    Pfenex has an office in San Diego.

  • How many offices does Pfenex have?

    Pfenex has 1 office.